SAB Biotherapeutics Inc. (SABS)
NASDAQ: SABS
· Real-Time Price · USD
1.93
0.05 (2.82%)
At close: May 14, 2025, 3:50 PM
1.85
-4.15%
After-hours: May 14, 2025, 04:00 PM EDT
SAB Biotherapeutics Revenue
SAB Biotherapeutics reported an annual revenue of $1.32M, reflecting a -40.94% growth. For the quarter ending March 31, 2025, SAB Biotherapeutics generated $0 in revenue.
Revenue (ttm)
$1.32M
Revenue Growth
-40.94%
Price / Sales Ratio
26.54
Revenue / Employee
$20.99K
Employees
63
Market Cap
17.93M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|